Barbara Scappini

Characteristics and outcome of patients with Philadelphia chromosome negative, <i>bcr</i>/<i>abl</i> negative chronic myelogenous leukemia

Francesco Onida, Greg Ball, Hagop M. Kantarjian et al. · Cancer · 2002 · 101 citations · Full text

Medicine, Hematology, Oncology +15

The proteasome inhibitor PS-341 inhibits growth and induces apoptosis in Bcr/Abl-positive cell lines sensitive and resistant to imatinib mesylate.

Simona Gatto, Barbara Scappini, Lan Pham et al. · PubMed · 2003 · 77 citations

Medicine, Oncology, Pharmacology +15

Mutation in the ATP-binding pocket of the ABL kinase domain in an STI571-resistant BCR/ABL-positive cell line.

Clara Ricci, Barbara Scappini, Vladimír Divoký et al. · PubMed · 2002 · 76 citations

Life Sciences, Biochemistry, Molecular Biology +17

<i>CEBPA</i> –double-mutated acute myeloid leukemia displays a unique phenotypic profile: a reliable screening method and insight into biological features

Francesco Mannelli, Vanessa Ponziani, Sara Bencini et al. · Haematologica · 2016 · 70 citations · Full text

Medicine, Hematology, Oncology +15

CPX-351 treatment in secondary acute myeloblastic leukemia is effective and improves the feasibility of allogeneic stem cell transplantation: results of the Italian compassionate use program

Fabio Guolo, Luana Fianchi, Paola Minetto et al. · Blood Cancer Journal · 2020 · 57 citations · Full text

Medicine, Hematology, Oncology +13